Ohio State Startup Raises $59 Million in Initial Funding to Treat 'Undruggable' Illness
December 19, 2018
December 19, 2018
COLUMBUS, Ohio, Dec. 19 -- Ohio State University issued the following news:
A biotechnology company with roots at The Ohio State University is making news after raising $59 million from investors.
Entrada Therapeutics is a biotechnology company developing new ways of treating devastating diseases by delivering drugs into target cells. The company was co-founded by Dehua Pei, Charles H. Kimberly Professor in Chemistry and Biochemistry at Ohio State.
The fun . . .
A biotechnology company with roots at The Ohio State University is making news after raising $59 million from investors.
Entrada Therapeutics is a biotechnology company developing new ways of treating devastating diseases by delivering drugs into target cells. The company was co-founded by Dehua Pei, Charles H. Kimberly Professor in Chemistry and Biochemistry at Ohio State.
The fun . . .